You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IgG1

Showing 1 - 25 of 4,045
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SARS CoV 2 Infection, SARS-CoV-2 Acute Respiratory Disease Trial in Bangkok (Human IgG1 anti-SARS-CoV-2 antibody cocktail,

Completed
  • SARS CoV 2 Infection
  • SARS-CoV-2 Acute Respiratory Disease
  • Human IgG1 anti-SARS-CoV-2 antibody cocktail
  • Placebo
  • Bangkok, Thailand
    National Cancer Institute of Thailand
Jul 5, 2022

Hematologic Malignancy Trial in Tianjin (IMM01)

Terminated
  • Hematologic Malignancy
  • Tianjin, Tianjin, China
    Chinese Academy of Medical Sciences and Peking Union Medical Col
May 5, 2023

Pulmonary Arterial Hypertension Trial (Sotatercept)

Not yet recruiting
  • Pulmonary Arterial Hypertension
  • Sotatercept
  • (no location specified)
Apr 5, 2023

Immune Complex-mediated Autoimmune Diseases Trial in Harrow (CSL730, Placebo)

Recruiting
  • Immune Complex-mediated Autoimmune Diseases
  • CSL730
  • Placebo
  • Harrow, United Kingdom
    PAREXEL Early Phase Clinical Unit (London), Northwick Park Hospi
Oct 3, 2022

Non Small Cell Lung Cancer Trial in Davis, Orlando, Columbus (ONC-392, Docetaxel)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Davis, California
  • +2 more
Jan 5, 2023

Lupus Nephritis Trial in Philippines, Taiwan (ANX009)

Recruiting
  • Lupus Nephritis
  • ANX009
  • Angeles City, Philippines
  • +6 more
Mar 10, 2023

Advanced Malignant Solid Tumor Trial in Sacramento (CD24 Extracellular Domain-IgG1 Fc Domain Recombinant Fusion Protein CD24Fc,

Terminated
Has Results
  • Advanced Malignant Solid Neoplasm
  • CD24 Extracellular Domain-IgG1 Fc Domain Recombinant Fusion Protein CD24Fc
  • Placebo Administration
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Mar 8, 2022

Generalized Pustular Psoriasis Trial in Shandong (HB0034)

Not yet recruiting
  • Generalized Pustular Psoriasis
  • Shandong, Shandong, China
    Shandong Provincial Dermatology Hospital
Aug 22, 2022

Metastatic Castration-resistant Prostate Cancer Trial (ONC-392, lutetium Lu 177 vipivotide tetraxetan 7.4 GBq (200 mCi), IV

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • ONC-392
  • lutetium Lu 177 vipivotide tetraxetan 7.4 GBq (200 mCi), IV infusion, Q6W for up to 6 doses.
  • (no location specified)
Dec 27, 2022

Anatomic Stage IV Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma Trial in Columbus (procedure, drug, biological)

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • HER2-Negative Breast Carcinoma
  • Biospecimen Collection
  • +5 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Aug 30, 2023

Tests for Visceral Leishmaniasis Diagnosis in Eastern Africa

Completed
  • Leishmaniasis, Visceral
  • Leishmania Ab Rapid Test (CTK, Biotech)
  • Gondar, Ethiopia
  • +1 more
Jun 1, 2022

West Nile Virus Trial in Baltimore (MGAWN1, Placebo)

Completed
  • West Nile Virus
  • Baltimore, Maryland
    PAREXEL Phase 1 Unit
Feb 4, 2022

Highly Sensitized Prospective Kidney Transplant Recipients Trial in San Francisco (daratumumab, belatacept, Bone marrow

Recruiting
  • Highly Sensitized Prospective Kidney Transplant Recipients
  • daratumumab
  • +2 more
  • San Francisco, California
    University of California at San Francisco Medical Center
Jan 27, 2022

Metastatic NSCLC (NSCLC) Trial in Sacramento (Avelumab, Stereotactic ablative radiotherapy (SAR))

Completed
  • Metastatic Non-small Cell Lung Cancer (NSCLC)
  • Avelumab
  • Stereotactic ablative radiotherapy (SAR)
  • Sacramento, California
    UC Davis
Oct 19, 2021

Recurrent ALK Positive Large B-Cell Lymphoma, Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between

Not yet recruiting
  • Recurrent ALK Positive Large B-Cell Lymphoma
  • +28 more
  • Biospecimen Collection
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Aug 17, 2022

Healthy Volunteers Trial in Philadelphia (INO-A002, CELLECTRA® 2000, Dengue Fever Antibodies (IgG))

Completed
  • Healthy Volunteers
  • INO-A002
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Nov 7, 2022

Responses to COVID-19 Vaccination in Patients With Cancer

Completed
  • Cancer
  • IgG neutralising antibody titers to S1 and S2 proteins of SARS-COV-2 virus
  • Athens, Attica, Greece
    Metropolitan Hospital
Aug 16, 2022

Healthy Subjects Trial in Grafton (HB0017, )

Completed
  • Healthy Subjects
  • Grafton, Auckland, New Zealand
    Auckland Clinical Studies Ltd
Jul 26, 2021

Health Status of Children Born After Assisted Reproductive

Recruiting
  • Children Born After Assisted Reproductive Technologies
  • +2 more
  • hemogram examination
  • Almaty, Kazakhstan
    Sevara ilmuratova
Oct 17, 2023

Healthy Trial in Groningen, London (CSL730, Placebo)

Terminated
  • Healthy
  • CSL730
  • Placebo
  • Groningen, Netherlands
  • +1 more
Jun 2, 2021

Neuroblastoma Trial in Madison, Southampton, London (Nivolumab, Ch14.18/CHO)

Recruiting
  • Neuroblastoma
  • Madison, Wisconsin
  • +2 more
Mar 28, 2022

COVID-19 Trial in London (Sample Collection/Performance Evaluation (A), Sample Collection/Performance Evaluation (B))

Suspended
  • COVID-19
  • Sample Collection/Performance Evaluation (A)
  • Sample Collection/Performance Evaluation (B)
  • London, United Kingdom
  • +2 more
Jun 6, 2022

HIV Trial run by the NIAID (CD4-IgG, Zidovudine, Interferon alfa-n1)

Completed
  • HIV Infections
  • Bethesda, Maryland
    Natl Inst of Allergy & Infect Dis / Cln Ctr
Oct 26, 2021

Anemia, MDS, Chronic Myelomonocytic Leukemia Trial in France, United States (Sotatercept)

Completed
Has Results
  • Anemia
  • +5 more
  • Denver, Colorado
  • +19 more
Oct 20, 2022

Dose Escalation Part: Locally Advanced or Metastatic Solid Tumor(s), Expansion Part: Prostate Cancer, Expansion Part: Esophageal

Terminated
  • Dose Escalation Part: Locally Advanced or Metastatic Solid Tumor(s)
  • +7 more
  • GEN1044 is an IgG1 bispecific antibody targeting CD3 and 5T4.
  • Nashville, Tennessee
  • +5 more
Mar 1, 2022